eligibility for semaglutide BMI & the Role of GLP-1 in Weight Loss Semaglutide Eligibility Across All Current
Description
Both are legitimate, mechanistically coherent, and encouraging as far as they go
You can ask for a printed copy or find it at www.msk.org/pe/goals_discharge_checklist

Yavari Kia, P., Safajou, F., Shahnazi, M., & Nazemiyeh, H
Prior Medication History: VA clinical guidelines require that you try and fail, or have a medical contraindication to, first-line generic diabetes medications (such as metformin) or other specific formulary alternatives before stepping up to a GLP-1
We therefore conclude that before the place of GLP-1/glucagon co-agonists within the therapeutic armamentarium can be defined, future research efforts need to address the following outstanding questions: What is the optimal balance and receptor potency of GLP-1 and glucagon in a long-acting co-agonist, to minimise adverse effects and to optimise efficacy ( Figure 2 )
